These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11459664)
21. Preparation of triazole-linked glycosylated α-ketocarboxylic acid derivatives as new PTP1B inhibitors. Song Z; He XP; Li C; Gao LX; Wang ZX; Tang Y; Xie J; Li J; Chen GR Carbohydr Res; 2011 Jan; 346(1):140-5. PubMed ID: 21111404 [TBL] [Abstract][Full Text] [Related]
22. Rhodanine derivatives as inhibitors of JSP-1. Cutshall NS; O'Day C; Prezhdo M Bioorg Med Chem Lett; 2005 Jul; 15(14):3374-9. PubMed ID: 15961311 [TBL] [Abstract][Full Text] [Related]
23. Biaryls and heterobiaryls as alpha-glucosidase and protein tyrosine phosphatase inhibitors. Sharon A; Pratap R; Tripathi B; Srivastava AK; Maulik PR; Ram VJ Bioorg Med Chem Lett; 2005 Mar; 15(5):1341-4. PubMed ID: 15713383 [TBL] [Abstract][Full Text] [Related]
24. Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases. Kotoris CC; Chen MJ; Taylor SD Bioorg Med Chem Lett; 1998 Nov; 8(22):3275-80. PubMed ID: 9873717 [TBL] [Abstract][Full Text] [Related]
26. 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B. Zhi Y; Gao LX; Jin Y; Tang CL; Li JY; Li J; Long YQ Bioorg Med Chem; 2014 Jul; 22(14):3670-83. PubMed ID: 24906513 [TBL] [Abstract][Full Text] [Related]
28. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening. Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ Bioorg Med Chem Lett; 2008 Apr; 18(7):2250-5. PubMed ID: 18358718 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Yersinia protein tyrosine phosphatase by phosphonate derivatives of calixarenes. Vovk AI; Kononets LA; Tanchuk VY; Cherenok SO; Drapailo AB; Kalchenko VI; Kukhar VP Bioorg Med Chem Lett; 2010 Jan; 20(2):483-7. PubMed ID: 20015646 [TBL] [Abstract][Full Text] [Related]
30. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation. Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331 [TBL] [Abstract][Full Text] [Related]
31. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases. Shen K; Qi L; Stiff L Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872 [TBL] [Abstract][Full Text] [Related]
32. Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Cui L; Na M; Oh H; Bae EY; Jeong DG; Ryu SE; Kim S; Kim BY; Oh WK; Ahn JS Bioorg Med Chem Lett; 2006 Mar; 16(5):1426-9. PubMed ID: 16356713 [TBL] [Abstract][Full Text] [Related]
33. Phosphonate derivatives of tetraazamacrocycles as new inhibitors of protein tyrosine phosphatases. Kobzar OL; Shevchuk MV; Lyashenko AN; Tanchuk VY; Romanenko VD; Kobelev SM; Averin AD; Beletskaya IP; Vovk AI; Kukhar VP Org Biomol Chem; 2015 Jul; 13(27):7437-44. PubMed ID: 26058329 [TBL] [Abstract][Full Text] [Related]
34. Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics. Jia Z; Ye Q; Dinaut AN; Wang Q; Waddleton D; Payette P; Ramachandran C; Kennedy B; Hum G; Taylor SD J Med Chem; 2001 Dec; 44(26):4584-94. PubMed ID: 11741477 [TBL] [Abstract][Full Text] [Related]
35. 6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitors. Baston E; Salem OI; Hartmann RW J Enzyme Inhib Med Chem; 2002 Oct; 17(5):303-20. PubMed ID: 12683747 [TBL] [Abstract][Full Text] [Related]
36. Asymmetric synthesis of the (S)-1,1-dioxido-isothiazolidin-3-one phosphotyrosine mimetic via reduction of a homochiral (R)-oxido-isothiazolidin-3-one. Combs AP; Glass B; Galya LG; Li M Org Lett; 2007 Mar; 9(7):1279-82. PubMed ID: 17338536 [TBL] [Abstract][Full Text] [Related]
37. alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship. Arabaci G; Yi T; Fu H; Porter ME; Beebe KD; Pei D Bioorg Med Chem Lett; 2002 Nov; 12(21):3047-50. PubMed ID: 12372498 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of alpha,alpha-difluorobenzylphosphonic acid derivatives as small molecular inhibitors of protein-tyrosine phosphatase 1B. Yokomatsu T; Murano T; Umesue I; Soeda S; Shimeno H; Shibuya S Bioorg Med Chem Lett; 1999 Feb; 9(4):529-32. PubMed ID: 10098656 [TBL] [Abstract][Full Text] [Related]
39. Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors. Zhang L; Qiu B; Xiong B; Li X; Li J; Wang X; Li J; Shen J Bioorg Med Chem Lett; 2007 Apr; 17(8):2118-22. PubMed ID: 17303416 [TBL] [Abstract][Full Text] [Related]
40. Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors. Lau CK; Bayly CI; Gauthier JY; Li CS; Therien M; Asante-Appiah E; Cromlish W; Boie Y; Forghani F; Desmarais S; Wang Q; Skorey K; Waddleton D; Payette P; Ramachandran C; Kennedy BP; Scapin G Bioorg Med Chem Lett; 2004 Feb; 14(4):1043-8. PubMed ID: 15013020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]